These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12526956)

  • 21. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
    Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sclerosing cholangitis and primary biliary cirrhosis. How effective is medical therapy?
    Fennerty MB
    Postgrad Med; 1993 Nov; 94(6):81-8; 92. PubMed ID: 8234100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
    Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
    Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of primary biliary cirrhosis.
    Poupon R; Poupon RE
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reflections on therapeutic trials in primary biliary cirrhosis.
    Combes B
    Hepatology; 2005 Nov; 42(5):1009. PubMed ID: 16250047
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.
    Abbas G; Lindor KD
    Expert Opin Pharmacother; 2010 Feb; 11(3):387-92. PubMed ID: 20102304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group.
    Poupon RE; Bonnand AM; Chrétien Y; Poupon R
    Hepatology; 1999 Jun; 29(6):1668-71. PubMed ID: 10347106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The timing of liver transplantation in primary biliary cirrhosis.
    Angulo P; Dickson ER
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):657-68. PubMed ID: 10976021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis.
    Leuschner U; Manns MP; Eisebitt R
    Z Gastroenterol; 2005 Sep; 43(9):1051-9. PubMed ID: 16142614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1989 May; 9(2):138-43. PubMed ID: 2658104
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid.
    Parés A; Caballería L; Rodés J
    Gastroenterology; 2006 Mar; 130(3):715-20. PubMed ID: 16530513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy.
    Terasaki S; Nakanuma Y; Ogino H; Unoura M; Kobayashi K
    Am J Gastroenterol; 1991 Sep; 86(9):1194-9. PubMed ID: 1882800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone.
    González-Koch A; Brahm J; Antezana C; Smok G; Cumsille MA
    J Hepatol; 1997 Jul; 27(1):143-9. PubMed ID: 9252088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
    Angulo P; Jorgensen RA; Lindor KD
    Am J Gastroenterol; 2001 Nov; 96(11):3152-7. PubMed ID: 11721764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
    J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
    Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis].
    Brodanová M; Perlík F
    Cas Lek Cesk; 1997 Apr; 136(7):215-20. PubMed ID: 9221197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.